SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis.
Zhao W, Wang X, Han L, Zhang C, Wang C, Kong D, Zhang M, Xu T, Li G, Hu G, Luo J, Yee SW, Yang J, Stahl A, Chen X, Zhang Y.
Zhao W, et al. Among authors: yee sw.
Nat Commun. 2024 Aug 30;15(1):7522. doi: 10.1038/s41467-024-51860-2.
Nat Commun. 2024.
PMID: 39215042
Free PMC article.